المؤلفون: A. O. Morozov, A. K. Bazarkin, S. V. Vovdenko, M. S. Taratkin, M. S. Balashova, D. V. Enikeev, А. О. Морозов, А. К. Базаркин, С. В. Вовденко, М. С. Тараткин, М. С. Балашова, Д. В. Еникеев

المصدر: Urology Herald; Том 12, № 1 (2024); 117-130 ; Вестник урологии; Том 12, № 1 (2024); 117-130 ; 2308-6424 ; 10.21886/2308-6424-2024-12-1

مصطلحات موضوعية: обзор литературы, machine learning, prostate cancer, molecular diagnostics, genetical diagnostics, review, машинное обучение, рак простаты, молекулярная диагностика, генетическая диагностика

وصف الملف: application/pdf

Relation: https://www.urovest.ru/jour/article/view/836/540; Barros-Silva D, Costa-Pinheiro P, Duarte H, Sousa EJ, Evangelista AF, Graça I, Carneiro I, Martins AT, Oliveira J, Carvalho AL, Marques MM, Henrique R, Jerónimo C. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis. Cell Death Dis. 2018;9(2):167. DOI:10.1038/s41419-017-0241-y; Zhou K, Arslanturk S, Craig DB, Heath E, Draghici S. Discovery of primary prostate cancer biomarkers using cross cancer learning. Sci Rep. 2021;11(1):10433. DOI:10.1038/s41598-021-89789-x; Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism. 2017;69S:S36-S40. DOI:10.1016/j.metabol.2017.01.011; Tizhoosh HR, Pantanowitz L. Artificial Intelligence and Digital Pathology: Challenges and Opportunities. J Pathol Inform. 2018;9:38. DOI:10.4103/jpi.jpi_53_18; Ramesh AN, Kambhampati C, Monson JR, Drew PJ. Artificial intelligence in medicine. Ann R Coll Surg Engl. 2004;86(5):334-8. DOI:10.1308/147870804290; Akkus Z, Cai J, Boonrod A, Zeinoddini A, Weston AD, Philbrick KA, Erickson BJ. A Survey of Deep-Learning Applications in Ultrasound: Artificial Intelligence-Powered Ultrasound for Improving Clinical Workflow. J Am Coll Radiol. 2019;16(9 Pt B):1318-1328. DOI:10.1016/j.jacr.2019.06.004; Mintz Y, Brodie R. Introduction to artificial intelligence in medicine. Minim Invasive Ther Allied Technol. 2019;28(2):73-81. DOI:10.1080/13645706.2019.1575882; Niel O, Bastard P. Artificial Intelligence in Nephrology: Core Concepts, Clinical Applications, and Perspectives. Am J Kidney Dis. 2019;74(6):803-810. DOI:10.1053/j.ajkd.2019.05.020; Ayyad SM, Shehata M, Shalaby A, Abou El-Ghar M, Ghazal M, El-Melegy M, Abdel-Hamid NB, Labib LM, Ali HA, ElBaz A. Role of AI and Histopathological Images in Detecting Prostate Cancer: A Survey. Sensors (Basel). 2021;21(8):2586. DOI:10.3390/s21082586; Тимофеева Е.Ю., Азильгареева К.Р., Морозов А.О., Тараткин М.С., Еникеев Д.В. Использование искусственного интеллекта в диагностике, лечении и наблюдении за пациентами с раком почки. Вестник урологии. 2023;11(3):142-148. DOI:10.21886/2308-6424-2023-11-3-142-148; Rajwa P, Schuettfort VM, Quhal F, Mori K, Katayama S, Laukhtina E, Pradere B, Motlagh RS, Mostafaei H, Grossmann NC, Aulitzky A, Paradysz A, Karakiewicz PI, Fajkovic H, Zimmermann K, Heidenreich A, Gontero P, Shariat SF. Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy. World J Urol. 2021;39(10):3771-3779. DOI:10.1007/s00345-021-03715-4; Yanagisawa T, Kawada T, Rajwa P, Mostafaei H, Motlagh RS, Quhal F, Laukhtina E, König F, Pallauf M, Pradere B, Karakiewicz PI, Nyirady P, Kimura T, Egawa S, Shariat SF. Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis. Urol Oncol. 2023;41(4):177-191. DOI:10.1016/j.urolonc.2022.06.018; Enikeev D, Morozov A, Babaevskaya D, Bazarkin A, Malavaud B. A Systematic Review of Circulating Tumor Cells Clinical Application in Prostate Cancer Diagnosis. Cancers (Basel). 2022;14(15):3802. DOI:10.3390/cancers14153802; Reichl F, Muhr D, Rebhan K, Kramer G, Shariat SF, Singer CF, Tan YY. Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline BRCA1 or BRCA2 Mutations. J Pers Med. 2021;11(9):917. DOI:10.3390/jpm11090917; Perera M, Mirchandani R, Papa N, Breemer G, Effeindzourou A, Smith L, Swindle P, Smith E. PSA-based machine learning model improves prostate cancer risk stratification in a screening population. World J Urol. 2021;39(6):1897-1902. DOI:10.1007/s00345-020-03392-9; Rodrigues VC, Soares JC, Soares AC, Braz DC, Melendez ME, Ribas LC, Scabini LFS, Bruno OM, Carvalho AL, Reis RM, Sanfelice RC, Oliveira ON Jr. Electrochemical and optical detection and machine learning applied to images of genosensors for diagnosis of prostate cancer with the biomarker PCA3. Talanta. 2021;222:121444. DOI:10.1016/j.talanta.2020.121444; Cario CL, Chen E, Leong L, Emami NC, Lopez K, Tenggara I, Simko JP, Friedlander TW, Li PS, Paris PL, Carroll PR, Witte JS. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer. BMC Cancer. 2020;20(1):820. DOI:10.1186/s12885-020-07318-x; Gumaei A, Sammouda R, Al-Rakhami M, AlSalman H, ElZaart A. Feature selection with ensemble learning for prostate cancer diagnosis from microarray gene expression. Health Informatics J. 2021;27(1):1460458221989402. DOI:10.1177/1460458221989402; Alshareef AM, Alsini R, Alsieni M, Alrowais F, Marzouk R, Abunadi I, Nemri N. Optimal Deep Learning Enabled Prostate Cancer Detection Using Microarray Gene Expression. J Healthc Eng. 2022;2022:7364704. DOI:10.1155/2022/7364704; Penney KL, Tyekucheva S, Rosenthal J, El Fandy H, Carelli R, Borgstein S, Zadra G, Fanelli GN, Stefanizzi L, Giunchi F, Pomerantz M, Peisch S, Coulson H, Lis R, Kibel AS, Fiorentino M, Umeton R, Loda M. Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum. Mol Cancer Res. 2021;19(3):475-484. DOI:10.1158/1541-7786.MCR-20-0548; Pachynski RK, Kim EH, Miheecheva N, Kotlov N, Ramachandran A, Postovalova E, Galkin I, Svekolkin V, Lyu Y, Zou Q, Cao D, Gaut J, Ippolito JE, Bagaev A, Bruttan M, Gancharova O, Nomie K, Tsiper M, Andriole GL, Ataullakhanov R, Hsieh JJ. Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer. Clin Cancer Res. 2021;27(12):3478-3490. DOI:10.1158/1078-0432.CCR-20-4217; Cosma G, McArdle SE, Foulds GA, Hood SP, Reeder S, Johnson C, Khan MA, Pockley AG. Prostate Cancer: Early Detection and Assessing Clinical Risk Using Deep Machine Learning of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data. Front Immunol. 2021;12:786828. DOI:10.3389/fimmu.2021.786828; Dadhania V, Gonzalez D, Yousif M, Cheng J, Morgan TM, Spratt DE, Reichert ZR, Mannan R, Wang X, Chinnaiyan A, Cao X, Dhanasekaran SM, Chinnaiyan AM, Pantanowitz L, Mehra R. Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer. BMC Cancer. 2022;22(1):494. DOI:10.1186/s12885-022-09559-4; Li R, Zhu J, Zhong WD, Jia Z. Comprehensive Evaluation of Machine Learning Models and Gene Expression Signatures for Prostate Cancer Prognosis Using Large Population Cohorts. Cancer Res. 2022;82(9):1832-1843. DOI:10.1158/0008-5472.CAN-21-3074; Williams C, Khondakar NR, Daneshvar MA, O'Connor LP, Gomella PT, Mehralivand S, Yerram NK, Egan J, Gurram S, Rompré-Brodeur A, Webster BR, Owens-Walton J, Parnes H, Merino MJ, Wood BJ, Choyke P, Turkbey B, Pinto PA. The Risk of Prostate Cancer Progression in Active Surveillance Patients with Bilateral Disease Detected by Combined Magnetic Resonance Imaging-Fusion and Systematic Biopsy. J Urol. 2021;206(5):1157-1165. DOI:10.1097/JU.0000000000001941; Hamzeh O, Alkhateeb A, Zheng J, Kandalam S, Rueda L. Prediction of tumor location in prostate cancer tissue using a machine learning system on gene expression data. BMC Bioinformatics. 2020;21(Suppl 2):78. DOI:10.1186/s12859-020-3345-9; Belinky F, Nativ N, Stelzer G, Zimmerman S, Iny Stein T, Safran M, Lancet D. PathCards: multi-source consolidation of human biological pathways. Database (Oxford). 2015;2015:bav006. DOI:10.1093/database/bav006; Guo H, Zhang Z, Wang Y, Xue S. Identification of crucial genes and pathways associated with prostate cancer in multiple databases. J Int Med Res. 2021;49(6):3000605211016624. DOI:10.1177/03000605211016624; Shamsara E, Shamsara J. Bioinformatics analysis of the genes involved in the extension of prostate cancer to adjacent lymph nodes by supervised and unsupervised machine learning methods: The role of SPAG1 and PLEKHF2. Genomics. 2020;112(6):3871-3882. DOI:10.1016/j.ygeno.2020.06.035; Xue J, Pu Y, Smith J, Gao X, Wang C, Wu B. Identifying metastatic ability of prostate cancer cell lines using native fluorescence spectroscopy and machine learning methods. Sci Rep. 2021;11(1):2282. DOI:10.1038/s41598-021-81945-7; Mansinho A, Macedo D, Fernandes I, Costa L. CastrationResistant Prostate Cancer: Mechanisms, Targets and Treatment. Adv Exp Med Biol. 2018;1096:117-133. DOI:10.1007/978-3-319-99286-0_7; Lin E, Hahn AW, Nussenzveig RH, Wesolowski S, Sayegh N, Maughan BL, McFarland T, Rathi N, Sirohi D, Sonpavde G, Swami U, Kohli M, Rich T, Sartor O, Yandell M, Agarwal N. Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform. Oncologist. 2021;26(9):751-760. DOI:10.1002/onco.13869; Paul N, Carabet LA, Lallous N, Yamazaki T, Gleave ME, Rennie PS, Cherkasov A. Cheminformatics Modeling of Adverse Drug Responses by Clinically Relevant Mutants of Human Androgen Receptor. J Chem Inf Model. 2016;56(12):2507-2516. DOI:10.1021/acs.jcim.6b00400; Bruce CL, Melville JL, Pickett SD, Hirst JD. Contemporary QSAR classifiers compared. J Chem Inf Model. 2007;47(1):219-27. DOI:10.1021/ci600332j; Wan Q, Pal R. An ensemble based top performing approach for NCI-DREAM drug sensitivity prediction challenge. PLoS One. 2014;9(6):e101183. DOI:10.1371/journal.pone.0101183; Gawehn E, Hiss JA, Schneider G. Deep Learning in Drug Discovery. Mol Inform. 2016;35(1):3-14. DOI:10.1002/minf.201501008; Ma J, Sheridan RP, Liaw A, Dahl GE, Svetnik V. Deep neural nets as a method for quantitative structure-activity relationships. J Chem Inf Model. 2015;55(2):263-74. DOI:10.1021/ci500747n; Rifaioglu AS, Atas H, Martin MJ, Cetin-Atalay R, Atalay V, Doğan T. Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases. Brief Bioinform. 2019;20(5):1878-1912. DOI:10.1093/bib/bby061; Snow O, Lallous N, Ester M, Cherkasov A. Deep Learning Modeling of Androgen Receptor Responses to Prostate Cancer Therapies. Int J Mol Sci. 2020;21(16):5847. DOI:10.3390/ijms21165847; Morozov A, Taratkin M, Bazarkin A, Rivas JG, Puliatti S, Checcucci E, Belenchon IR, Kowalewski KF, Shpikina A, Singla N, Teoh JYC, Kozlov V, Rodler S, Piazza P, Fajkovic H, Yakimov M, Abreu AL, Cacciamani GE, Enikeev D; Young Academic Urologists (YAU) Working Group in Uro-technology of the European Association of Urology. A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading. Prostate Cancer Prostatic Dis. 2023;26(4):681-692. DOI:10.1038/s41391-023-00673-3; Kowalewski KF, Egen L, Fischetti CE, Puliatti S, Juan GR, Taratkin M, Ines RB, Sidoti Abate MA, Mühlbauer J, Wessels F, Checcucci E, Cacciamani G; Young Academic Urologists (YAU)-Urotechnology-Group. Artificial intelligence for renal cancer: From imaging to histology and beyond. Asian J Urol. 2022;9(3):243-252. DOI:10.1016/j.ajur.2022.05.003; Zeng J, Cheng Q, Zhang D, Fan M, Shi C, Luo L. Diagnostic Ability of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prostate Cancer and Clinically Significant Prostate Cancer in Equivocal Lesions: A Systematic Review and Meta-Analysis. Front Oncol. 2021;11:620628. DOI:10.3389/fonc.2021.620628; https://www.urovest.ru/jour/article/view/836

الاتاحة: https://www.urovest.ru/jour/article/view/836
https://doi.org/10.21886/2308-6424-2024-12-1-117-130

المؤلفون: E. Yu. Timofeeva, С. R. Azilgareeva, A. O. Morozov, M. S. Taratkin, D. V. Enikeev, Е. Ю. Тимофеева, К. Р. Азильгареева, А. О. Морозов, М. С. Тараткин, Д. В. Еникеев

المصدر: Urology Herald; Том 11, № 3 (2023); 142-148 ; Вестник урологии; Том 11, № 3 (2023); 142-148 ; 2308-6424 ; 10.21886/2308-6424-2023-11-3

مصطلحات موضوعية: лечение, artificial intelligence, diagnosis, treatment, искусственный интеллект, диагностика

وصف الملف: application/pdf

Relation: https://www.urovest.ru/jour/article/view/764/502; Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356-387. DOI:10.1016/j.ejca.2018.07.005; Thorstenson A, Bergman M, Scherman-Plogell AH, Hosseinnia S, Ljungberg B, Adolfsson J, Lundstam S. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register. Scand J Urol. 2014;48(3):231-8. DOI:10.3109/21681805.2013.864698; Xu Q, Zhu Q, Liu H, Chang L, Duan S, Dou W, Li S, Ye J. Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists. J Magn Reson Imaging. 2022;55(4):1251-1259. DOI:10.1002/jmri.27900; Enikeev D, Morozov A, Bazarkin A, Shpikina A, Brill B, Teoh JY, Suvorov A, Singla N, Taratkin M, Rivas JG, Barret E; ESUT Ablative Group. Thermal ablation vs. active surveillance for renal masses: a systematic review and network meta-analysis. Minerva Urol Nephrol. 2023;75(2):154-162. DOI:10.23736/S2724-6051.22.05036-4; Rabinowitz MJ, Esfandiary T, Cheaib J, Patel SH, Alam R, Metcalf M, Enikeev D, Pierorazio PM, Ged YMA, Allaf ME, Singla N. Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma. Eur Urol Open Sci. 2022;43:28-34. DOI:10.1016/j.euros.2022.07.001; Watson DS, Krutzinna J, Bruce IN, Griffiths CE, McInnes IB, Barnes MR, Floridi L. Clinical applications of machine learning algorithms: beyond the black box. BMJ. 2019;364:l886. DOI:10.1136/bmj.l886; Roberts S, Desai A, Checcucci E, Puliatti S, Taratkin M, Kowalewski KF, Gomez Rivas J, Rivero I, Veneziano D, Autorino R, Porpiglia F, Gill IS, Cacciamani GE. "Augmented reality" applications in urology: a systematic review. Minerva Urol Nephrol. 2022;74(5):528-537. DOI:10.23736/S2724-6051.22.04726-7; Hameed BMZ, S Dhavileswarapu AVL, Raza SZ, Karimi H, Khanuja HS, Shetty DK, Ibrahim S, Shah MJ, Naik N, Paul R, Rai BP, Somani BK. Artificial Intelligence and Its Impact on Urological Diseases and Management: A Comprehensive Review of the Literature. J Clin Med. 2021;10(9):1864. DOI:10.3390/jcm10091864; Gómez Rivas J, Toribio Vázquez C, Ballesteros Ruiz C, Taratkin M, Marenco JL, Cacciamani GE, Checcucci E, Okhunov Z, Enikeev D, Esperto F, Grossmann R, Somani B, Veneziano D. Artificial intelligence and simulation in urology. Actas Urol Esp (Engl Ed). 202;45(8):524-529. (In English, Spanish). DOI:10.1016/j.acuroe.2021.07.001.; Garrow CR, Kowalewski KF, Li L, Wagner M, Schmidt MW, Engelhardt S, Hashimoto DA, Kenngott HG, Bodenstedt S, Speidel S, Müller-Stich BP, Nickel F. Machine Learning for Surgical Phase Recognition: A Systematic Review. Ann Surg. 2021;273(4):684-693. DOI:10.1097/SLA.0000000000004425; Tsili AC, Andriotis E, Gkeli MG, Krokidis M, Stasinopoulou M, Varkarakis IM, Moulopoulos LA; Oncologic Imaging Subcommittee Working Group of the Hellenic Radiological Society. The role of imaging in the management of renal masses. Eur J Radiol. 2021;141:109777. DOI:10.1016/j.ejrad.2021.109777; Kaur R, Juneja M, Mandal AK. An overview of non-invasive imaging modalities for diagnosis of solid and cystic renal lesions. Med Biol Eng Comput. 2020;58(1):1-24. DOI:10.1007/s11517-019-02049-z; Tanaka T, Huang Y, Marukawa Y, Tsuboi Y, Masaoka Y, Kojima K, Iguchi T, Hiraki T, Gobara H, Yanai H, Nasu Y, Kanazawa S. Differentiation of Small (≤ 4 cm) Renal Masses on Multiphase Contrast-Enhanced CT by Deep Learning. AJR Am J Roentgenol. 2020;214(3):605-612. Erratum in: AJR Am J Roentgenol. 2020;214(4):945. PMID: 31913072. DOI:10.2214/AJR.19.22074; Ursprung S, Beer L, Bruining A, Woitek R, Stewart GD, Gallagher FA, Sala E. Radiomics of computed tomography and magnetic resonance imaging in renal cell carcinoma-a systematic review and meta-analysis. Eur Radiol. 2020;30(6):3558-3566. DOI:10.1007/s00330-020-06666-3; Гордуладзе Д.Н., Сирота Е.С., Рапопорт Л.М., Гридин В.Н., Цариченко Д.Г., Кузнецов И.А., Бочкарев П.В., Аляев Ю.Г. Возможности текстурного анализа лучевых методов визуализации в диагностике образований паренхимы почки. Онкоурология. 2021;17(4):129-135.DOI:10.17650/1726-9776-2021-17-4-129-135; Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2016;278(2):563-77. DOI:10.1148/radiol.2015151169; Mühlbauer J, Egen L, Kowalewski KF, Grilli M, Walach MT, Westhoff N, Nuhn P, Laqua FC, Baessler B, Kriegmair MC. Radiomics in Renal Cell Carcinoma-A Systematic Review and Meta-Analysis. Cancers (Basel). 2021;13(6):1348. DOI:10.3390/cancers13061348; Ma Y, Cao F, Xu X, Ma W. Can whole-tumor radiomics-based CT analysis better differentiate fat-poor angiomyolipoma from clear cell renal cell caricinoma: compared with conventional CT analysis? Abdom Radiol (NY). 2020;45(8):2500-2507. DOI:10.1007/s00261-020-02414-9; Goh V, Ganeshan B, Nathan P, Juttla JK, Vinayan A, Miles KA. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology. 2011;261(1):165-71. DOI:10.1148/radiol.11110264; Li Y, Huang X, Xia Y, Long L. Value of radiomics in differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Abdom Radiol (NY). 2020;45(10):3193-3201. DOI:10.1007/s00261-019-02269-9; Nassiri N, Maas M, Cacciamani G, Varghese B, Hwang D, Lei X, Aron M, Desai M, Oberai AA, Cen SY, Gill IS, Duddalwar VA. A Radiomic-based Machine Learning Algorithm to Reliably Differentiate Benign Renal Masses from Renal Cell Carcinoma. Eur Urol Focus. 2022;8(4):988-994. DOI:10.1016/j.euf.2021.09.004; Kocak B, Kaya OK, Erdim C, Kus EA, Kilickesmez O. Artificial Intelligence in Renal Mass Characterization: A Systematic Review of Methodologic Items Related to Modeling, Performance Evaluation, Clinical Utility, and Transparency. AJR Am J Roentgenol. 2020;215(5):1113-1122. DOI:10.2214/AJR.20.22847; Piramide F, Kowalewski KF, Cacciamani G, Rivero Belenchon I, Taratkin M, Carbonara U, Marchioni M, De Groote R, Knipper S, Pecoraro A, Turri F, Dell'Oglio P, Puliatti S, Amparore D, Volpi G, Campi R, Larcher A, Mottrie A, Breda A, Minervini A, Ghazi A, Dasgupta P, Gozen A, Autorino R, Fiori C, Di Dio M, Gomez Rivas J, Porpiglia F, Checcucci E; European Association of Urology Young Academic Urologists and the European Section of Uro-Technology. Three-dimensional Model-assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies. Eur Urol Oncol. 2022;5(6):640-650. DOI:10.1016/j.euo.2022.09.003; Doyle PW, Kavoussi NL. Machine learning applications to enhance patient specific care for urologic surgery. World J Urol. 2022;40(3):679-686. DOI:10.1007/s00345-021-03738-x; Amparore D, Pecoraro A, Checcucci E, Piramide F, Verri P, De Cillis S, Granato S, Angusti T, Solitro F, Veltri A, Fiori C, Porpiglia F. Three-dimensional Virtual Models' Assistance During Minimally Invasive Partial Nephrectomy Minimizes the Impairment of Kidney Function. Eur Urol Oncol. 2022;5(1):104-108. DOI:10.1016/j.euo.2021.04.001; Schiavina R, Bianchi L, Chessa F, Barbaresi U, Cercenelli L, Lodi S, Gaudiano C, Bortolani B, Angiolini A, Bianchi FM, Ercolino A, Casablanca C, Molinaroli E, Porreca A, Golfieri R, Diciotti S, Marcelli E, Brunocilla E. Augmented Reality to Guide Selective Clamping and Tumor Dissection During Robot-assisted Partial Nephrectomy: A Preliminary Experience. Clin Genitourin Cancer. 2021;19(3):e149-e155. DOI:10.1016/j.clgc.2020.09.005; Puliatti S, Eissa A, Checcucci E, Piazza P, Amato M, Ferretti S, Scarcella S, Rivas JG, Taratkin M, Marenco J, Rivero IB, Kowalewski KF, Cacciamani G, El-Sherbiny A, Zoeir A, El-Bahnasy AM, De Groote R, Mottrie A, Micali S. New imaging technologies for robotic kidney cancer surgery. Asian J Urol. 2022;9(3):253-262. DOI:10.1016/j.ajur.2022.03.008; Porpiglia F, Checcucci E, Amparore D, Piramide F, Volpi G, Granato S, Verri P, Manfredi M, Bellin A, Piazzolla P, Autorino R, Morra I, Fiori C, Mottrie A. Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥10): A New Intraoperative Tool Overcoming the Ultrasound Guidance. Eur Urol. 2020;78(2):229-238. DOI:10.1016/j.eururo.2019.11.024; Nosrati MS, Amir-Khalili A, Peyrat JM, Abinahed J, Al-Alao O, Al-Ansari A, Abugharbieh R, Hamarneh G. Endoscopic scene labelling and augmentation using intraoperative pulsatile motion and colour appearance cues with preoperative anatomical priors. Int J Comput Assist Radiol Surg. 2016;11(8):1409-18. DOI:10.1007/s11548-015-1331-x; Morozov A, Taratkin M, Bazarkin A, Rivas JG, Puliatti S, Checcucci E, Belenchon IR, Kowalewski KF, Shpikina A, Singla N, Teoh JYC, Kozlov V, Rodler S, Piazza P, Fajkovic H, Yakimov M, Abreu AL, Cacciamani GE, Enikeev D; Young Academic Urologists (YAU) Working Group in Uro-technology of the European Association of Urology. A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading. Prostate Cancer Prostatic Dis. 2023. Epub ahead of print. PMID: 37185992. DOI:10.1038/s41391-023-00673-3.; Nagpal K, Foote D, Tan F, Liu Y, Chen PC, Steiner DF, Manoj N, Olson N, Smith JL, Mohtashamian A, Peterson B, Amin MB, Evans AJ, Sweet JW, Cheung C, van der Kwast T, Sangoi AR, Zhou M, Allan R, Humphrey PA, Hipp JD, Gadepalli K, Corrado GS, Peng LH, Stumpe MC, Mermel CH. Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens. JAMA Oncol. 2020;6(9):1372-1380. DOI:10.1001/jamaoncol.2020.2485; Lee M, Wei S, Anaokar J, Uzzo R, Kutikov A. Kidney cancer management 3.0: can artificial intelligence make us better? Curr Opin Urol. 2021;31(4):409-415. DOI:10.1097/MOU.0000000000000881; Tabibu S, Vinod PK, Jawahar CV. Pan-Renal Cell Carcinoma classification and survival prediction from histopathology images using deep learning. Sci Rep. 2019;9(1):10509. DOI:10.1038/s41598-019-46718-3; Tian K, Rubadue CA, Lin DI, Veta M, Pyle ME, Irshad H, Heng YJ. Automated clear cell renal carcinoma grade classification with prognostic significance. PLoS One. 2019;14(10):e0222641. DOI:10.1371/journal.pone.0222641; Fenstermaker M, Tomlins SA, Singh K, Wiens J, Morgan TM. Development and Validation of a Deep-learning Model to Assist With Renal Cell Carcinoma Histopathologic Interpretation. Urology. 2020;144:152-157. DOI:10.1016/j.urology.2020.05.094; Khene ZE, Bigot P, Doumerc N, Ouzaid I, Boissier R, Nouhaud FX, Albiges L, Bernhard JC, Ingels A, Borchiellini D, Kammerer-Jacquet S, Rioux-Leclercq N, Roupret M, Acosta O, De Crevoisier R, Bensalah K; Collaborators. Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma. Eur Urol Oncol. 2023;6(3):323-330. DOI:10.1016/j.euo.2022.07.007; Kim H, Lee SJ, Park SJ, Choi IY, Hong SH. Machine Learning Approach to Predict the Probability of Recurrence of Renal Cell Carcinoma After Surgery: Prediction Model Development Study. JMIR Med Inform. 2021;9(3):e25635. DOI:10.2196/25635; Kim HM, Byun SS, Kim JK, Jeong CW, Kwak C, Hwang EC, Kang SH, Chung J, Kim YJ, Ha YS, Hong SH. Machine learning-based prediction model for late recurrence after surgery in patients with renal cell carcinoma. BMC Med Inform Decis Mak. 2022;22(1):241. DOI:10.1186/s12911-022-01964-w; https://www.urovest.ru/jour/article/view/764

الاتاحة: https://www.urovest.ru/jour/article/view/764
https://doi.org/10.21886/2308-6424-2023-11-3-142-148

المؤلفون: A. A. Androsov, L. L. Chuvalov, M. S. Taratkin, D. O. Korolev, Yu. P. Gorobets, L. M. Rapoport, D. V. Enikeev, D. G. Tsarichenko, M. E. Enikeev, А. А. Андросов, Л. Л. Чувалов, М. С. Тараткин, Д. О. Королев, Ю. П. Горобец, Л. М. Рапопорт, Д. В. Еникеев, Д. Г. Цариченко, М. Э. Еникеев

المصدر: Urology Herald; Том 11, № 3 (2023); 87-97 ; Вестник урологии; Том 11, № 3 (2023); 87-97 ; 2308-6424 ; 10.21886/2308-6424-2023-11-3

مصطلحات موضوعية: радиоволновая терапия, physical therapy modalities, radiowave therapy, low-intensity extracorporeal shock wave therapy, физиотерапия, ударно-волновая терапия

وصف الملف: application/pdf

Relation: https://www.urovest.ru/jour/article/view/759/497; Salonia A, Bettocchi C, Capogrosso P, Carvalho J, Corona G, Hatzichristodoulou G, Jones TH, Kadioglu A, Martinez-Salamanca JI, Minhas S, Serefoglu EC, Verze P. Sexual and Reproductive Health. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6; Чалый М.Е., Ахвледиани Н.Д., Харчилава Р.Р. Российские клинические рекомендации. Эректильная дисфункция. Урология. 2017;2 (supplement):20-29. DOI:10.18565/urol.2017.2-supplement.20-29; Пушкарь Д.Ю., Куликов А.Г., Касян Г.Р., Куприянов Ю.А., Ромих В.В., Захарченко А.В., Воронина Д.Д., Ярустовская О.В., Зайцева Т.Н. Экстракорпоральная магнитная стимуляция нервно-мышечного аппарата тазового дна в урологической практике. Физиотерапия, бальнеология и реабилитация. 2019;18(4):264-276. DOI:10.17816/1681-3456-2019-18-4-264-276; Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. DOI:10.1016/s0022-5347(17)34871-1; Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171(20):1797-803. DOI:10.1001/archinternmed.2011.440; Ventimiglia E, Capogrosso P, Montorsi F, Salonia A. The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction. Expert Opin Drug Saf. 2016;15(2):141-52. DOI:10.1517/14740338.2016.1131818; Ефремов Е.А., Касатонова Е.В., Мельник Я.И. Применение силденафила цитрата при эректильной дисфункции различной этиологии. Урология. 2015;(2);117-121. eLIBRARY ID: 23608528; EDN: TWQGPB; Чувалов Л.Л., Королёв Д.О., Горобец Ю.П., Фиев Д.Н., Лумпов И.С., Иванян Г.И., Штеренгарц С.Н., Фокин И.В., Еникеев М.Э., Олефир Ю.В. Современные технологии и новые тенденции в консервативном лечении эректильной дисфункции. Вопросы урологии и андрологии. 2021;9(1):27-34. DOI:10.20953/2307-6631-2021-1-27-34; Katz JE, Clavijo RI, Rizk P, Ramasamy R. The Basic Physics of Waves, Soundwaves, and Shockwaves for Erectile Dysfunction. Sex Med Rev. 2020;8(1):100-105. DOI:10.1016/j.sxmr.2019.09.004; van der Lugt C, Romero C, Ancona D, Al-Zarouni M, Perera J, Trelles MA. A multicenter study of cellulite treatment with a variable emission radio frequency system. Dermatol Ther. 2009;22(1):74-84. DOI:10.1111/j.1529-8019.2008.01218.x; Porst H. Review of the Current Status of Low Intensity Extracorporeal Shockwave Therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie's Disease (PD), and Sexual Rehabilitation After Radical Prostatectomy With Special Focus on Technical Aspects of the Different Marketed ESWT Devices Including Personal Experiences in 350 Patients. Sex Med Rev. 2021;9(1):93-122. DOI:10.1016/j.sxmr.2020.01.006; Qiu X, Lin G, Xin Z, Ferretti L, Zhang H, Lue TF, Lin CS. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med. 2013;10(3):738-46. DOI:10.1111/jsm.12024; Li H, Matheu MP, Sun F, Wang L, Sanford MT, Ning H, Banie L, Lee YC, Xin Z, Guo Y, Lin G, Lue TF. Low-energy Shock Wave Therapy Ameliorates Erectile Dysfunction in a Pelvic Neurovascular Injuries Rat Model. J Sex Med. 2016;13(1):22-32. Erratum in: J Sex Med. 2016;13(4):732. PMID: 26755082. DOI:10.1016/j.jsxm.2015.11.008; Sokolakis I, Dimitriadis F, Teo P, Hatzichristodoulou G, Hatzichristou D, Giuliano F. The Basic Science Behind Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Scoping Review of Pre-Clinical Studies. J Sex Med. 2019;16(2):168-194. DOI:10.1016/j.jsxm.2018.12.016; Wang B, Ning H, Reed-Maldonado AB, Zhou J, Ruan Y, Zhou T, Wang HS, Oh BS, Banie L, Lin G, Lue TF. Low-Intensity Extracorporeal Shock Wave Therapy Enhances Brain-Derived Neurotrophic Factor Expression through PERK/ATF4 Signaling Pathway. Int J Mol Sci. 2017;18(2):433. DOI:10.3390/ijms18020433; Sokolakis I, Dimitriadis F, Psalla D, Karakiulakis G, Kalyvianakis D, Hatzichristou D. Effects of low-intensity shock wave therapy (LiST) on the erectile tissue of naturally aged rats. Int J Impot Res. 2019;31(3):162-169. DOI:10.1038/s41443-018-0064-0; Vinay J, Moreno D, Rajmil O, Ruiz-Castañe E, Sanchez-Curbelo J. Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: a randomized double-blind sham-controlled clinical trial. World J Urol. 2021;39(6):2217-2222. DOI:10.1007/s00345-020-03373-y; Baccaglini W, Pazeto CL, Corrêa Barros EA, Timóteo F, Monteiro L, Saad Rached RY, Navas A, Glina S. The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial. J Sex Med. 2020;17(4):688-694. DOI:10.1016/j.jsxm.2019.12.024; Patel P, Katz J, Lokeshwar SD, Molina M, Reis IM, Clavijo R, Ramasamy R. Phase II Randomized, Clinical Trial Evaluating 2 Schedules of Low-Intensity Shockwave Therapy for the Treatment of Erectile Dysfunction. Sex Med. 2020;8(2):214-222. DOI:10.1016/j.esxm.2020.01.010; Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol. 2012;187(5):1769-75. DOI:10.1016/j.juro.2011.12.117; Srini VS, Reddy RK, Shultz T, Denes B. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population. Can J Urol. 2015;22(1):7614-22. PMID: 25694008.; Fojecki GL, Tiessen S, Osther PJS. Effect of Linear Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction-12-Month Follow-Up of a Randomized, Double-Blinded, Sham-Controlled Study. Sex Med. 2018;6(1):1-7. DOI:10.1016/j.esxm.2017.09.002; Fojecki GL, Tiessen S, Osther PJ. Effect of Low-Energy Linear Shockwave Therapy on Erectile Dysfunction-A Double-Blinded, Sham-Controlled, Randomized Clinical Trial. J Sex Med. 2017;14(1):106-112. DOI:10.1016/j.jsxm.2016.11.307; Adeldaeim HM, Abouyoussif T, Gebaly OE, Assem A, Wahab MMA, Rashad H, Sakr M, Zahran AR. Prognostic Indicators for Successful Low-intensity Extracorporeal Shock Wave Therapy Treatment of Erectile Dysfunction. Urology. 2021;149:133-139. DOI:10.1016/j.urology.2020.12.019; Hernández-Bule ML, Martínez-Botas J, Trillo MÁ, Paíno CL, Úbeda A. Antiadipogenic effects of subthermal electric stimulation at 448 kHz on differentiating human mesenchymal stem cells. Mol Med Rep. 2016;13(5):3895-903. DOI:10.3892/mmr.2016.5032; Чувалов Л.Л., Королев Д.О., Азильгареева К.Р., Тараткин М.С., Олефир Ю.В., Фиев Д.Н., Лумпов И.С., Горобец Ю.П., Еникеев Д.В., Рапопорт Л.М., Еникеев М.Э. Радиоволновая электротерапия с радиочастотой 448 кгц в лечении пациентов с органической эректильной дисфункцией: проспективное рандомизированное простое слепое Sham-контролируемое исследование в параллельных группах. Урология. 2022;(2):54-58. DOI:10.18565/urology.2022.2.54-58; Gruenwald I, Appel B, Shechter A, Greenstein A. Radiofrequency energy in the treatment of erectile dysfunction-a novel cohort pilot study on safety, applicability, and short-term efficacy. Int J Impot Res. 2023 Aug 17. Epub ahead of print. PMID: 37592175. DOI:10.1038/s41443-023-00733-1; Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011;60(5):1010-6. DOI:10.1016/j.eururo.2011.07.053; Wu SS, Ericson KJ, Shoskes DA. Retrospective comparison of focused shockwave therapy and radial wave therapy for men with erectile dysfunction. Transl Androl Urol. 2020;9(5):2122-2128. DOI:10.21037/tau-20-911; Ghahhari J, De Nunzio C, Lombardo R, Ferrari R, Gatti L, Ghidini N, Piazza RC, Faieta A, Cindolo L. Shockwave Therapy for Erectile Dysfunction: Which Gives the Best Results? A Retrospective National, Multi-Institutional Comparative Study of Different Shockwave Technologies. Surg Technol Int. 2022;40:213-218. DOI:10.52198/22.STI.40.UR1556; Yao H, Wang X, Liu H, Sun F, Tang G, Bao X, Wu J, Zhou Z, Ma J. Systematic Review and Meta-Analysis of 16 Randomized Controlled Trials of Clinical Outcomes of Low-Intensity Extracorporeal Shock Wave Therapy in Treating Erectile Dysfunction. Am J Mens Health. 2022;16(2):15579883221087532. DOI:10.1177/15579883221087532; Rho BY, Kim SH, Ryu JK, Kang DH, Kim JW, Chung DY. Efficacy of Low-Intensity Extracorporeal Shock Wave Treatment in Erectile Dysfunction Following Radical Prostatectomy: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11(10):2775. DOI:10.3390/jcm11102775; Осадчинский А.Е., Виноградов И.В., Даренков С.П. Вакуум индуцированная эрекция – профилактика гипоксии кавернозной ткани у пациентов после радикальной простатэктомии. Вестник урологии. 2018;6(1):48-54. DOI:10.21886/2308-6424-2018-6-1-48-54; Карнаух П.А., Яйцев С.В., Важенин А.В., Золотых М.А., Перетрухин А.А. Профилактика и лечение эректильной дисфункции у пациентов после радикальной нервосберегающей простатэктомии. Вестник урологии. 2015;(4):50-64. DOI:10.21886/2308-6424-2015-0-4-50-64; https://www.urovest.ru/jour/article/view/759

الاتاحة: https://www.urovest.ru/jour/article/view/759
https://doi.org/10.21886/2308-6424-2023-11-3-87-97

المؤلفون: V. S. Petov, A. K. Bazarkin, E. S. Krupinov, A. O. Morozov, M. S. Taratkin, A. F. Abdusalamov, A. V. Amosov, D. V. Enikeev, В. С. Петов, А. К. Базаркин, Е. С. Крупинов, А. О. Морозов, М. С. Тараткин, А. Ф. Абдусаламов, А. В. Амосов, Д. В. Еникеев

المصدر: Urology Herald; Том 10, № 4 (2022); 88-97 ; Вестник урологии; Том 10, № 4 (2022); 88-97 ; 2308-6424 ; 10.21886/2308-6424-2022-10-4

مصطلحات موضوعية: гистологическая эффективность, biopsy, mpMR/US-fusion biopsy, cognitive biopsy, histology, effectiveness, клинически значимый рак простаты, мпМР/УЗ-фьюжн биопсия, когнитивная биопсия

وصف الملف: application/pdf

Relation: https://www.urovest.ru/jour/article/view/628/437; Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Çek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE; GPIU investigators. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol. 2013;63(3):521-7. https://dx.doi.org/10.1016/j.eururo.2012.06.003; Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142(1):71-4; discussion 74-5. https://dx.doi.org/10.1016/s0022-5347(17)38664-0; Ploussard G, Nicolaiew N, Marchand C, Terry S, Allory Y, Vacherot F, Abbou CC, Salomon L, de la Taille A. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial. BJU Int. 2013;111(6):988-96. https://dx.doi.org/10.1111/j.1464-410X.2012.11607.x; Bass EJ, Pantovic A, Connor MJ, Loeb S, Rastinehad AR, Winkler M, Gabe R, Ahmed HU. Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2022;25(2):174-179. https://dx.doi.org/10.1038/s41391-021-00449-7; Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014;65(6):1046-55. https://dx.doi.org/10.1016/j.eururo.2013.12.062; Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, Rosario DJ, Scattoni V, Lotan Y. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876-92. https://dx.doi.org/10.1016/j.eururo.2013.05.049; Lam TBL, MacLennan S, Willemse PM, Mason MD, Plass K, Shepherd R, Baanders R, Bangma CH, Bjartell A, Bossi A, Briers E, Briganti A, Buddingh KT, Catto JWF, Colecchia M, Cox BW, Cumberbatch MG, Davies J, Davis NF, De Santis M, Dell'Oglio P, Deschamps A, Donaldson JF, Egawa S, Fankhauser CD, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Gross T, Grummet JP, Henry AM, Ingels A, Irani J, Lardas M, Liew M, Lin DW, Moris L, Omar MI, Pang KH, Paterson CC, Renard-Penna R, Ribal MJ, Roobol MJ, Rouprêt M, Rouvière O, Sancho Pardo G, Richenberg J, Schoots IG, Sedelaar JPM, Stricker P, Tilki D, Vahr Lauridsen S, van den Bergh RCN, Van den Broeck T, van der Kwast TH, van der Poel HG, van Leenders GJLH, Varma M, Violette PD, Wallis CJD, Wiegel T, Wilkinson K, Zattoni F, N'Dow JMO, Van Poppel H, Cornford P, Mottet N. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). Eur Urol. 2019;76(6):790-813. https://dx.doi.org/10.1016/j.eururo.2019.09.020; Norris JM, Kinnaird A, Margolis DJ, Padhani AR, Walz J, Kasivisvanathan V. Developments in MRI-targeted prostate biopsy. Curr Opin Urol. 2020;30(1):1-8. https://dx.doi.org/10.1097/MOU.0000000000000683; Panebianco V, Barchetti F, Manenti G, Aversa T, Catalano C, Simonetti G. MR imaging-guided prostate biopsy: technical features and preliminary results. Radiol Med. 2015;120(6):571-8. https://dx.doi.org/10.1007/s11547-014-0490-0; Verma S, Choyke PL, Eberhardt SC, Oto A, Tempany CM, Turkbey B, Rosenkrantz AB. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology. 2017;285(2):343-356. https://dx.doi.org/10.1148/radiol.2017161684; Stabile A, Dell'Oglio P, Gandaglia G, Fossati N, Brembilla G, Cristel G, Dehò F, Scattoni V, Maga T, Losa A, Gaboardi F, Cardone G, Esposito A, De Cobelli F, Del Maschio A, Montorsi F, Briganti A. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Eur Urol Oncol. 2018;1(2):120-128. https://dx.doi.org/10.1016/j.euo.2018.02.002; Elkhoury FF, Felker ER, Kwan L, Sisk AE, Delfin M, Natarajan S, Marks LS. Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study. JAMA Surg. 2019;154(9):811-818. https://dx.doi.org/10.1001/jamasurg.2019.1734; Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W, de Bruin PC, Bosch JLHR, Barentsz JO, Somford DM, van Melick HHE. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. Eur Urol. 2019;75(4):582-590. https://dx.doi.org/10.1016/j.eururo.2018.11.040; Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, Puech P, Punwani S, Rosenkrantz AB, Schoots IG, Simon R, Taneja SS, Turkbey B, Ukimura O, van der Meulen J, Villers A, Watanabe Y; START Consortium. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol. 2013;64(4):544-52. https://dx.doi.org/10.1016/j.eururo.2013.03.030; Hsieh PF, Chang TY, Lin WC, Chang H, Chang CH, Huang CP, Yang CR, Chen WC, Chang YH, Wang YD, Huang WC, Wu HC. A comparative study of transperineal software-assisted magnetic resonance/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate. BMC Urol. 2022;22(1):72. https://dx.doi.org/10.1186/s12894-022-01011-w; Liang L, Cheng Y, Qi F, Zhang L, Cao D, Cheng G, Hua L. A Comparative Study of Prostate Cancer Detection Rate Between Transperineal COG-TB and Transperineal FUS-TB in Patients with PSA ≤20 ng/mL. J Endourol. 2020;34(10):1008-1014. https://dx.doi.org/10.1089/end.2020.0276; Kaufmann S, Russo GI, Bamberg F, Löwe L, Morgia G, Nikolaou K, Stenzl A, Kruck S, Bedke J. Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy. World J Urol. 2018;36(5):761-768. https://dx.doi.org/10.1007/s00345-018-2189-7; Watts KL, Frechette L, Muller B, Ilinksy D, Kovac E, Sankin A, Aboumohamed A. Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer. Urol Oncol. 2020;38(9):734.e19-734.e25. https://dx.doi.org/10.1016/j.urolonc.2020.03.020; Pepe P, Garufi A, Priolo G, Pennisi M. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer. Clin Genitourin Cancer. 2017;15(1):e33-e36. https://dx.doi.org/10.1016/j.clgc.2016.07.007; Valerio M, McCartan N, Freeman A, Punwani S, Emberton M, Ahmed HU. Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer. Urol Oncol. 2015;33(10):424.e9-16. https://dx.doi.org/10.1016/j.urolonc.2015.06.012; Kam J, Yuminaga Y, Kim R, Aluwihare K, Macneil F, Ouyang R, Ruthven S, Louie-Johnsun M. Does magnetic resonance imaging-guided biopsy improve prostate cancer detection? A comparison of systematic, cognitive fusion and ultrasound fusion prostate biopsy. Prostate Int. 2018;6(3):88-93. https://dx.doi.org/10.1016/j.prnil.2017.10.003; Oderda M, Faletti R, Battisti G, Dalmasso E, Falcone M, Marra G, Palazzetti A, Zitella A, Bergamasco L, Gandini G, Gontero P. Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study. Urol Int. 2016;97(2):230-7. https://dx.doi.org/10.1159/000445524; https://www.urovest.ru/jour/article/view/628

الاتاحة: https://www.urovest.ru/jour/article/view/628
https://doi.org/10.21886/2308-6424-2022-10-4-88-97

المؤلفون: D. I. Babaevskaya, A. K. Bazarkin, M. S. Taratkin, D. V. Enikeev, Д. И. Бабаевская, А. К. Базаркин, М. С. Тараткин, Д. В. Еникеев

المصدر: Urology Herald; Том 10, № 1 (2022); 96-103 ; Вестник урологии; Том 10, № 1 (2022); 96-103 ; 2308-6424 ; 10.21886/2308-6424-2022-10-1

مصطلحات موضوعية: обзор, transurethral resection of bladder tumor, non-muscle invasive bladder cancer, review, трансуретральная резекция стенки мочевого пузыря с опухолью, мышечно-неинвазивный рак мочевого пузыря

وصف الملف: application/pdf

Relation: https://www.urovest.ru/jour/article/view/527/387; Capogrosso P, Capitanio U, Ventimiglia E, Boeri L, Briganti A, Colombo R, Montorsi F, Salonia A. Detrusor Muscle in TUR-Derived Bladder Tumor Specimens: Can We Actually Improve the Surgical Quality? J Endourol. 2016;30(4):400-5. DOI:10.1089/end.2015.0591; Mariappan P, Zachou A, Grigor KM; Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57(5):843-9. DOI:10.1016/j.eururo.2009.05.047; Ontario Health (Quality). Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment. Ont Health Technol Assess Ser. 2021;21(12):1-123. PMID: 34484486; PMCID: PMC8382283; Bach T, Muschter R, Herrmann TR, Knoll T, Scoffone CM, Laguna MP, Skolarikos A, Rischmann P, Janetschek G, De la Rosette JJ, Nagele U, Malavaud B, Breda A, Palou J, Bachmann A, Frede T, Geavlete P, Liatsikos E, Jichlinski P, Schwaibold HE, Chlosta P, Martov AG, Lapini A, Schmidbauer J, Djavan B, Stenzl A, Brausi M, Rassweiler JJ. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives. BJU Int. 2015;115(1):14-23. DOI:10.1111/bju.12664; Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Drăgoescu O, Ray E, Fradet Y, Karl A, Burgués JP, Witjes JA, Stenzl A, Jichlinski P, Jocham D. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013;64(5):846-54. DOI:10.1016/j.eururo.2013.03.059; Schraml J, Silva JDC, Babjuk M. Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection. Curr Opin Urol. 2018;28(6):591-597. DOI:10.1097/MOU.0000000000000542; Mowatt G, N'Dow J, Vale L, Nabi G, Boachie C, Cook JA, Fraser C, Griffiths TR; Aberdeen Technology Assessment Review (TAR) Group. Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis. Int J Technol Assess Health Care. 2011;27(1):3-10. DOI:10.1017/S0266462310001364; Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, Nseyo U, Droller MJ; PC B302/01 Study Group. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol. 2007;178(1):62-7. DOI:10.1016/j.juro.2007.03.034; Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, Yoshida S, Hamamoto Y, Endo T. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 2004;9(3):568-77. DOI:10.1117/1.1695563; Xiong Y, Li J, Ma S, Ge J, Zhou L, Li D, Chen Q. A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer. PLoS One. 2017;12(2):e0170819. DOI:10.1371/journal.pone.0170819; Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Escrig JLD, Hernández V, Peyronnet B, Seisen T, Soukup V. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol. 2019;76(5):639-657. DOI:10.1016/j.eururo.2019.08.016; Drejer D, Béji S, Oezeke R, Nielsen AM, Høyer S, Bjerklund Johansen TE, Lam GW, Jensen JB. Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa-8 Study. Urology. 2017;102:138-142. DOI:10.1016/j.urology.2016.11.032; EAU Guidelines: Non-muscle-invasive Bladder Cancer. Available at: https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/#note_125-128. Accessed December 7, 2020.; Cocci A, Patruno G, Gandaglia G, Rizzo M, Esperto F, Parnanzini D, Pietropaolo A, Principi E, Talso M, Baldesi R, Battaglia A, Shehu E, Carrobbio F, Corsaro A, La Rocca R, Marchioni M, Bianchi L, Miglioranza E, Mantica G, Martorana E, Misuraca L, Fontana D, Forte S, Napoli G, Russo GI; Senato degli Specializzandi Study Group. Urology Residency Training in Italy: Results of the First National Survey. Eur Urol Focus. 2018;4(2):280-287. DOI:10.1016/j.euf.2016.06.006; Poletajew S, Krajewski W, Kaczmarek K, Kopczyński B, Stamirowski R, Tukiendorf A, Zdrojowy R, Słojewski M, Radziszewski P. The Learning Curve for Transurethral Resection of Bladder Tumour: How Many is Enough to be Independent, Safe and Effective Surgeon? J Surg Educ. 2020;77(4):978-985. DOI:10.1016/j.jsurg.2020.02.010; Suarez-Ibarrola R, Soria F, Abufaraj M, D'Andrea D, Preto M, Gust KM, Briganti A, Shariat SF, Gontero P. Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour. BJU Int. 2019;123(4):646-650. DOI:10.1111/bju.14557; Mostafid H, Kamat AM, Daneshmand S, Palou J, Taylor JA 3rd, McKiernan J, Catto J, Babjuk M, Soloway M. Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. Eur Urol Oncol. 2021;4(1):12-19. DOI:10.1016/j.euo.2020.06.010; Kawada T, Ebihara K, Suzuki T, Imai K, Yamanaka H. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol. 1997;157(6):2225-6. PMID: 9146621; Hurle R, Casale P, Lazzeri M, Paciotti M, Saita A, Colombo P, Morenghi E, Oswald D, Colleselli D, Mitterberger M, Kunit T, Hager M, Herrmann TRW, Lusuardi L. En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study. World J Urol. 2020;38(3):703-708. DOI:10.1007/s00345-019-02805-8; Hayashida Y, Miyata Y, Matsuo T, Ohba K, Sakai H, Taba M, Naito S, Taniguchi K. A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer. BMC Urol. 2019;19(1):56. DOI:10.1186/s12894-019-0486-0; Zhang KY, Xing JC, Li W, Wu Z, Chen B, Bai DY. A novel transurethral resection technique for superficial bladder tumor: retrograde en bloc resection. World J Surg Oncol. 2017;15(1):125. DOI:10.1186/s12957-017-1192-6; Cheng YY, Sun Y, Li J, Liang L, Zou TJ, Qu WX, Jiang YZ, Ren W, Du C, Du SK, Zhao WC. Transurethral endoscopic submucosal en bloc dissection for nonmuscle invasive bladder cancer: A comparison study of HybridKnife-assisted versus conventional dissection technique. J Cancer Res Ther. 2018;14(7):1606-1612. DOI:10.4103/jcrt.JCRT_786_17; Zhang D, Yao L, Yu S, Cheng Y, Jiang J, Ma Q, Yan Z. Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary nonmuscle-invasive bladder cancer: a meta-analysis. World J Surg Oncol. 2020;18(1):4. DOI:10.1186/s12957-019-1776-4; Teoh JY, MacLennan S, Chan VW, Miki J, Lee HY, Chiong E, Lee LS, Wei Y, Yuan Y, Yu CP, Chow WK, Poon DM, Chan R, Lai F, Ng CF, Breda A, Kramer MW, Malavaud B, Mostafid H, Herrmann T, Babjuk M. An International Collaborative Consensus Statement on En bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting. Eur Urol. 2020;78(4):546-569. DOI:10.1016/j.eururo.2020.04.059; Fritsche HM, Otto W, Eder F, Hofstädter F, Denzinger S, Chaussy CG, Stief C, Wieland WF, Burger M. Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study. J Endourol. 2011;25(10):1599-603. DOI:10.1089/end.2011.0042; Geavlete B, Multescu R, Georgescu D, Stanescu F, Jecu M, Geavlete P. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors--results of a prospective, randomized comparison to the standard approach. Urology. 2012;79(4):846-51. DOI:10.1016/j.urology.2011.08.081; Enikeev D, Taratkin M, Margulis V, Sorokin NI, Severgina L, Paramonova N, Kislyakov D, Kozlov V, Rapoport L, Shariat S, Glybochko P. Safety and Short-Term Oncological Outcomes of Thulium Fiber Laser En bloc Resection of Non-Muscle-Invasive Bladder Cancer: A Prospective Non-Randomized Phase II Trial. Bladder Cancer. 2020;6:1-10. DOI:10.3233/BLC-200275; Zhao C, Tang K, Yang H, Xia D, Chen Z. Bipolar Versus Monopolar Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: A Meta-Analysis. J Endourol. 2016;30(1):5-12. DOI:10.1089/end.2015.0410; Venkatramani V, Panda A, Manojkumar R, Kekre NS. Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. J Urol. 2014;191(6):1703-7. DOI:10.1016/j.juro.2013.12.004; Hashem A, Mosbah A, El-Tabey NA, Laymon M, Ibrahiem EH, Elhamid MA, Elshal AM. Holmium Laser En-bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle-invasive Bladder Cancer: A Randomized Clinical Trial. Eur Urol Focus. 2021;7(5):1035-1043. DOI:10.1016/j.euf.2020.12.003; Wolters M, Kramer MW, Becker JU, Christgen M, Nagele U, Imkamp F, Burchardt M, Merseburger AS, Kuczyk MA, Bach T, Gross AJ, Herrmann TR. Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol. 2011;29(4):429-32. DOI:10.1007/s00345-011-0686-z; Teichmann HO, Herrmann TR, Bach T. Technical aspects of lasers in urology. World J Urol. 2007;25(3):221-5. DOI:10.1007/s00345-007-0184-5; Chen X, Liao J, Chen L, Qiu S, Mo C, Mao X, Yang Y, Zhou S, Chen J. En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial. World J Urol. 2015;33(7):989-95. DOI:10.1007/s00345-014-1342-1; Enikeev D, Traxer O, Taratkin M, Okhunov Z, Shariat S. A review of thulium-fiber laser in stone lithotripsy and soft tissue surgery. Curr Opin Urol. 2020;30(6):853-860. DOI:10.1097/MOU.0000000000000815; Taratkin M, Kovalenko A, Laukhtina E, Paramonova N, Spivak L, Wachtendorf LJ, Eminovic S, Afyouni AS, Okhunov Z, Karagezyan M, Mikhailov V, Strakhov Y, Herrmann TR, Enikeev D. Ex vivo study of Ho:YAG and thulium fiber lasers for soft tissue surgery: which laser for which case? Lasers Med Sci. 2022;37(1):149-154. DOI:10.1007/s10103-020-03189-7; Kramer MW, Rassweiler JJ, Klein J, Martov A, Baykov N, Lusuardi L, Janetschek G, Hurle R, Wolters M, Abbas M, von Klot CA, Leitenberger A, Riedl M, Nagele U, Merseburger AS, Kuczyk MA, Babjuk M, Herrmann TR. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015;33(12):1937-43. DOI:10.1007/s00345-015-1568-6; Mundhenk J, Alloussi SH, Miller F, Hennenlotter J, Gakis G, Schilling D, Stenzl A, Schwentner C. En-bloc resection of non-muscle invasive bladder tumours with the combination instrument HybridKnife®. Eur Urol Suppl 2013;12:eV59. DOI:10.1016/S1569-9056(13)61642-5; Nagele U, Kugler M, Nicklas A, Merseburger AS, Walcher U, Mikuz G, Herrmann TR. Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection. World J Urol. 2011;29(4):423-7. DOI:10.1007/s00345-011-0653-8; Becker B, Enikeev D, Glybochko P, Rapoport L, Taratkin M, Gross AJ, Vinnichenko V, Herrmann TRW, Netsch C. Effect of optical fiber diameter and laser emission mode (cw vs pulse) on tissue damage profile using 1.94 µm Tm:fiber lasers in a porcine kidney model. World J Urol. 2020;38(6):1563-1568. DOI:10.1007/s00345-019-02944-y; https://www.urovest.ru/jour/article/view/527

الاتاحة: https://www.urovest.ru/jour/article/view/527
https://doi.org/10.21886/2308-6424-2022-10-1-96-103

المؤلفون: D. V. Enikeev, L. M. Rapoport, A. V. Amosov, M. E. Enikeev, D. V. Chinenov, O. V. Snurnitsyna, A. N. Gerasimov, Z. K. Dzhalaev, M. Ya. Gaas, E. A. Laukhtina, M. S. Taratkin, Д. В. Еникеев, Л. М. Рапопорт, А. В. Амосов, М. Э. Еникеев, Д. В. Чиненов, О. В. Снурницына, А. Н. Герасимов, З. К. Джалаев, М. Я. Гаас, Е. А. Лаухтина, М. С. Тараткин

المصدر: Cancer Urology; Том 14, № 3 (2018); 43-50 ; Онкоурология; Том 14, № 3 (2018); 43-50 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2018-14-3

مصطلحات موضوعية: малоинвазивная терапия, cryoablation, brachytherapy, HIFU therapy, complication, ablation, minimally invasive therapy, криоаблация, брахитерапия, HIFU-терапия, осложнение, аблация

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/844/784; Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63(1):11–30. DOI:10.3322/caac.21166. PMID: 23335087.; Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67(1):7–30. PMID: 28055103. DOI:10.3322/caac.21387.; Bell K.J., Del Mar C., Wright G. et al. Prevalence of incidental prostate cancer: A systematic review of autopsy studies. Int J Cancer 2015;137(7):1749–57. DOI:10.1002/ijc.29538. PMID: 25821151.; Mottet N., Bellmunt J., Bolla M. et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and local treatment. Eur Urol 2017;71(4):618–29. DOI:10.1016/j.eururo.2016.08.003. PMID: 27568654.; Ficarra V., Novara G., Artibani W. et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009;55(5):1037–63. DOI:10.1016/j.eururo.2009.01.036. PMID: 19185977.; Coelho R.F., Rocco B., Patel M.B. et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol 2010;24(12):2003–15. DOI:10.1089/end.2010.0295. PMID: 20942686.; Marien A., Gill I., Ukimura O. et al. Target ablation-image-guided therapy in prostate cancer. Urol Onol 2014;32(6):912–23. DOI:10.1016/j.urolonc.2013.10.014. PMID: 24411788.; Coleman J.A., Scardino P.T. Targeted prostate cancer ablation: energy options. Curr Opin Urol 2013;23(2):123–8. DOI:10.1097/MOU.0b013e32835d9e94. PMID: 23287462.; Rees J., Patel B., MacDonagh R., Persad R. Cryosurgery for prostate cancer. BJU Int 2004;93(6):710–4. DOI:10.1111/j.1464-410X.2003.04746.x. PMID: 15049977.; Han K.R., Belldegrun A.S. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 2004;93(1):14–8. PMID: 14678360.; Aus G. Current status of HIFU and cryotherapy in prostate cancer – a review. Eur Urol 2006;50(5):927–34. DOI:10.1016/j.eururo.2006.07.011. PMID: 16971038.; Cordeiro E.R., Cathelineau X., Thüroff S. et al. High-intensity focused ultra-sound (HIFU) for definitive treatment of prostate cancer. BJU Int 2012;110(9):1228–42. DOI:10.1111/j.1464-410X.2012.11262.x. PMID: 22672199.; Clyne M. Prostate cancer: prostatic swelling and shift upon HIFU. Nat Rev Urol 2013;10(6):306. DOI:10.1038/nrurol.2013.98. PMID: 23628808.; Shoji S., Uchida T., Nakamoto M. et al. Prostate swelling and shift during high intensity focused ultrasound: implication for targeted focal therapy. J Urol 2013;190(4):1224–32. DOI:10.1016/j.juro.2013.03.116. PMID: 23583532.; Rebillard X., Soulié M., Chartier-Kastler E. et al. HIFU in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int 2008;101(10):1205–13. DOI:10.1111/j.1464-410X.2008.07504.x. PMID: 18325057.; De Bari B., Daidone A., Alongi F. Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature. Crit Rev Oncol Hematol 2015;94(3):360–70. DOI:10.1016/j.critrevonc.2015.02.003. PMID: 25819287.; National Institute for Health and Care Excellence (NICE). Prostate Cancer: Diagnosis and Treatment. Full Guidance. CG58, 2008.; US Department of Health and Human Services: Agency for Healthcare Research and Quality. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer. Health Care Bulletin No. 13, 2008.; US Department of Health and Human Services: Agency for Healthcare Research and Quality. Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: An Update, 2010.; Pisansky T.M., Hunt D., Gomella L.G. et al. Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. J Clin Oncol 2015;33(4):332–9. DOI:10.1200/JCO.2014.58.0662. PMID: 25534388.; Hinnen K.A., Battermann J.J., van Roermund J.G. et al. Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2010;76(5):1433–8. DOI:10.1016/j.ijrobp.2009.03.049. PMID: 19540075.; Cornu J.N., Merlet B., Ciofu C. et al. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial. Eur Urol 2011;59(1):148–54. DOI:10.1016/j.eururo.2010.10.031. PMID: 21030144.; Filocamo M.T., Li Marzi V., Del Popolo G. et al. Pharmacologic treatment in postprostatectomy stress urinary incontinence. Eur Urol 2007;51(6):1559–64. DOI:10.1016/j.eururo.2006.08.005. PMID: 16942833.; Alan C., Eren A.E., Ersay A.R. et al. Efficacy of duloxetine in the early management of urinary continence after radical prostatectomy. Curr Urol 2015;8(1):43–8. DOI:10.1159/000365688. PMID: 26195963.; Geraerts I., Van Poppel H., Devoogdt N. et al. Influence of preoperative and postoperative pelvic floor muscle training (PFMT) compared with postoperative PFMT on urinary incontinence after radical prostatectomy: a randomized controlled trial. Eur Urol 2013;64(5):766–72. DOI:10.1016/j.eururo.2013.01.013. PMID: 23357349.; Campbell S.E., Glazener C.M., Hunter K.F. et al. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev 2012;1. DOI:10.1002/14651858.CD001843.pub4. PMID: 22258946.; Schröder A., Abrams P., Andersson K.E. et al. Guidelines on urinary incontinence. In: EAU guidelines. European Association of Urology. Ed. A.G. Arnheim. Arnheim, the Netherlands, 2010. Pp. 11–28.; Imamoglu M.A., Tuygun C., Bakirtas H. et al. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence. Eur Urol 2005;47(2):209–13. DOI:10.1016/j.eururo.2004.08.019. PMID: 15661416.; Secin F.P., Martínez-Salamanca J.I., Eilber K.S. Limited efficacy of permanent injectable agents in the treatment of stress urinary incontinence after radical prostatectomy. Arch Esp Urol 2005;58(5):431–6. PMID: 16078785.; Bauer R.M., Soljanik I., Füllhase C. et al. Results of the Advance transobturator male sling after radical prostatectomy and adjuvant radiotherapy. Urology 2011;77(2):474–9. DOI:10.1016/j.urology.2010.07.541. PMID: 21167563.; Cornu J.N., Sèbe P., Ciofu C. et al. Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors. BJU Int 2011;108(2):236–40. DOI:10.1111/j.1464-410X.2010.09765.x. PMID: 20955265.; Silva L.A., Andriolo R.B., Atallah A.N., da Silva E.M. Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. Cochrane Database Syst Rev 2011;(4):CD008306. DOI:10.1002/14651858.CD008306.pub2. PMID: 21491408.; Herschorn S., Bruschini H., Comiter C. et al. Surgical treatment of stressincontinence in men. Neurourol Urodyn 2010;29(1):179–90. DOI:10.1002/nau.20844. PMID: 20025026.; Ramsay C.R., Adewuyi T.E., Gray J. et al. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation. Health Technol Assess 2015;19(49):1–490. DOI:10.3310/hta19490. PMID: 26140518.; Ward J.F., Jones J.S. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int 2012;109(11):1648–54. DOI:10.1111/j.1464-410X.2011.10578.x. PMID: 22035200.; Ohashi T., Yorozu A., Toya K. et al. Predictive factors of acute urinary retention requiring catheterization following 125I prostate brachytherapy. Jpn J Clin Oncol 2006;36(5):285–9. DOI:10.1093/jjco/hyl008. PMID: 16698803.; Bucci J., Morris W.J., Keyes M. et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002;53(1):91–8. PMID: 12007946.; Pellizzon A.C., Salvajoli J.V., Maia M.A. et al. Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. J Urol 2004;171(3):1105–8. DOI:10.1097/01.ju.0000113260.07979.d3. PMID: 14767280.; Henderson A., Ismail A.K., Cunningham M. et al. Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK. A prospective study. Clin Oncol (R Coll Radiol) 2004;16(2):95–104. PMID: 15074730.; Martens C., Pond G., Webster D. et al. Relationship of the international prostate symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy. Brachytherapy 2006;5(1):9–13. DOI:10.1016/j.brachy.2005.12.002. PMID: 16563992.; Allardice J.T., Standfield N.J., Wyatt A.P. Acute urinary retention: which catheter? Ann R Coll Surg Engl 1988;70(6):366–8. PMID: 3207328.; Fitzpatrick J.M., Desgrandchamps F., Adjali K. et al. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. BJU Int 2012;109(1):88–95. DOI:10.1111/j.1464-410X.2011.10430.x. PMID: 22117624.; Ahyai S.A., Gilling P., Kaplan S.A. et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010;58(3):384–97. DOI:10.1016/j.eururo.2010.06.005. PMID: 20825758.; Chi A.C., Han J., Gonzalez C.M. Urethral strictures and the cancer survivor Curr Opin Urol 2014;24(4):415–20. DOI:10.1097/MOU.0000000000000070. PMID: 24809412.; Rourke K., Kinnaird A., Zorn J. Observations and outcomes of urethroplasty for bulbomembranous stenosis after radiation therapy for prostate cancer. World J Urol 2016;34(3):377–82. DOI:10.1007/s00345-015-1608-2. PMID: 26047655.; Elliott S.P., Meng M.V., Elkin E.P. et al. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. J Urol 2007;178(2):529–34. DOI:10.1016/j.juro.2007.03.126. PMID: 17570425.; Borboroglu P.G., Sands J.P., Roberts J.L et al. Risk factors for vesicourethral anastomotic stricture after radical prostatectomy. Urology 2000;56(1):96–100. PMID: 10869633.; Sandhu J.S., Gotto G.T., Herran L.A. et al. Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy. J Urol 2011;185(6):2148–52. DOI:10.1016/j.juro.2011.02.003. PMID: 21496848.; Mundy A.R., Andrich D.E. Posterior urethral complications of the treatment of prostate cancer. BJU Int 2012;110(3):304–25. DOI:10.1111/j.1464-410X.2011.10864.x. PMID: 22340079.; Bryk D.J., Yamaguchi Y., Zhao L.C. Tissue transfer techniques in reconstructive urology. Korean J Urol 2015;56(7):478–86. DOI:10.4111/kju.2015.56.7.478. PMID: 26175866.; Meeks J.J., Erickson B.A., Granieri M.A. et al. Stricture recurrence after urethroplasty: a systematic review. J Urol 2009;182(4):1266–70. DOI:10.1016/j.juro.2009.06.027. PMID: 19683309.; Herschorn S., Elliott S.P., Coburn M. et al. SIU/ICUD consultation on urethral strictures: posterior urethral stenosis after treatment of prostate cancer, Urology 2014;83(3 Suppl):S59–70. DOI:10.1016/j.urology.2013.08.036. PMID: 24361008.; Sanda M.G., Dunn R.L., Michalski J. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358(12):1250–61. DOI:10.1056/NEJMoa074311. PMID: 18354103.; Ficarra V., Novara G., Ahlering T.E. et al. Systematic review and meta-analysis of studies reporting potency rates after robotassisted radical prostatectomy. Eur Urol 2012;62(3):418–30. DOI:10.1016/j.eururo.2012.05.046. PMID: 22749850.; Incrocci L., Jensen P.T. Pelvic radiotherapy and sexual function in men and women. J Sex Med 2013;10(Suppl 1):53–64. DOI:10.1111/jsm.12010. PMID: 23387912.; Ellis D.S., Manny J., Rewcastle J.C. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology 2007;70(6 Suppl):9–15. DOI:10.1016/j.urology.2007.07.036. PMID: 18194712.; Poissonnier L., Chapelon J.Y., Rouvière O. et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007;51(2):381–7. DOI:10.1016/j.eururo.2006.04.012. PMID: 16857310.; Merrick G.S., Wallner K.E., Butler W.M. Prostate cryotherapy: more questions than answers. Urology 2005;66(1):9–15. DOI:10.1016/j.urology.2004.12.039. PMID: 15992870.; Nehra A., Jackson G., Miner M. et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2012;87(8):766–78. DOI:10.1016/j.mayocp.2012.06.015. PMID: 22862865.; Swearingen D., Nehra A., Morelos S., Peterson C.A. Hemodynamic effect of avanafil and glyceryl trinitrate coadministration. Drugs Context 2013;2013:212–48. DOI:10.7573/dic.212248. PMID: 24432037.; Yu Y.F., Nichol M.B., Yu A.P., Ahn J. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program. Value Health 2005;8(4):495–505. DOI:10.1111/j.1524-4733.2005.00041.x. PMID: 16091027.; Kalder M., Pantazis K., Dinas K. et al. Discontinuation of treatment using anticholinergic medications in patients with urinary incontinence. Obstet Gynecol 2014;124(4):794–800. DOI:10.1097/AOG.0000000000000468. PMID: 25198276.; Coombs P.G., Heck M., Guhring P. et al. A review of outcomes of an intracavernosal injection therapy programme. BJU Int 2012;110(11):1787–91. DOI:10.1111/j.1464-410X.2012.11080.x. PMID: 22564343.; Porst H., Burnett A., Brock G. et al. SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 2013;10(1):130–71. DOI:10.1111/jsm.12023. PMID: 23343170.; Antonini G., Busetto G.M., De Berardinis E. et al. Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: Evaluation of efficacy, satisfaction profile and complications. Int J Impot Res 2016;28(1):4–8. DOI:10.1038/ijir.2015.33. PMID: 26657316.; Elliott S.P., McAninch J.W., Chi T. et al. Management of severe urethral complications of prostate cancer therapy. J Urol 2006;176(6 Pt 1):2508–13. DOI:10.1016/j.juro.2006.07.152. PMID: 17085144.; Walsh P.C., Partin A.W. Anatomic radical retropubic prostatectomy. In: Campbell-Walsh Urology. Saunders Elsevier, Philadelphia, Pa, USA, 9th edn, 2006.; Noldus J., Fernandez S., Huland H. Rectourinary fistula repair using the Latzko technique. J Urol 1999;161(5):1518–20. PMID: 10210386.; Bahn D.K., Lee F., Badalament R. et al.Targeted cryoablation of the prostate: 7-year outcomes in the primary treat ment of prostate cancer. Urology 2002;60(2 Suppl 1):3–11. PMID: 12206842.; Mack D., Jungwirth A., Adam U. et al. Long-term follow-up after open perineal cryotherapy in patients with locally confined prostate cancer. Eur Urol 1997;32(2):129–32. PMID: 9286641.; Thomas C., Jones J., Jager W. et al. Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy. J Urol 2010;183(2):608– 12. DOI:10.1016/j.juro.2009.10.020. PMID: 20018317.; dal Moro F., Mancini M., Pinto F. et al. Successful repair of latrogenic rectourinary fistulas using the posterior sagittal transrectal approach: 15-year experience. World J Surg 2006;30(1):107–13.; Renschler T.D., Middleton R.G. 30 years of experience with York-Mason repair of recto-urinary fistulas. J Urol 2003; 170(4 Pt 1):1222–5. DOI:10.1097/01.ju.0000082013.58783.17. PMID: 14501729.; https://oncourology.abvpress.ru/oncur/article/view/844

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/844
https://doi.org/10.17650/1726-9776-2018-14-3-43-50

المؤلفون: P. V. Glybochko, Yu. G. Alyaev, L. M. Rapoport, D. V. Enikeev, N. D. Akhvlediani, L. G. Spivak, Ya. N. Chernov, E. A. Laukhtina, A. V. Dymova, M. S. Taratkin, П. В. Глыбочко, Ю. Г. Аляев, Л. М. Рапопорт, Д. В. Еникеев, Н. Д. Ахвледиани, Л. Г. Спивак, Я. Н. Чернов, Е. А. Лаухтина, А. В. Дымова, М. С. Тараткин

المصدر: Andrology and Genital Surgery; Том 18, № 4 (2017); 12-18 ; Андрология и генитальная хирургия; Том 18, № 4 (2017); 12-18 ; 2412-8902 ; 2070-9781 ; 10.17650/2070-9781-2017-18-4

مصطلحات موضوعية: эректильная функция, benign prostatic hyperplasia, transurethral resection, thulium and holmium laser enucleation, infravesical obstruction, erectile function, доброкачественная гиперплазия предстательной железы, трансуретральная резекция, тулиевая и гольмиевая лазерная энуклеация, инфравезикальная обструкция

وصف الملف: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/255/238; Vuichoud C., Loughlin R. K. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 2015;22:1–6. PMID: 26497338.; Rosen R., Altweinb J., Boylec P. et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637–49. PMID: 14644114.; Gacci M., Bartoletti R., Figlioli S. Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study. Br J Urol Int 2003;91:196–200. PMID: 12581003.; Cha J. S., Park J. K. Association between lower urinary tract symptoms and erectile dysfunction. Korean J Urol 2005;46:1023–7.; Jung J. H., Jae S. U., Kam S. C., Hyun J. S. Correlation between Lower Urinary Tract Symptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact of treatment of LUTS on sexual function. J Sex Med 2009;6:2299–304. DOI:10.1111/j.1743- 6109.2009.01324.x. PMID: 19493292.; Tscholl R., Largo M., Poppinghaus H. et al. Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests. J Urol 1995;153(5):1491–3. PMID: 7536253.; Hanbury D., Sethia K. Erectile function following transurethral prostatectomy. Br J Urol 1995;75:12–3. PMID: 7850292.; Bieri S., Iselin C. E., Rohner S. Capsular perforation localization and adenoma size as prognosis indicator of erectile dysfunctional after transurethral prostatectomy. Scand J Urol Nephrol 1997;31(6):545–8. PMID: 9458513.; Choi S. B., Zhao C., Park J. K. The effect of transurethral resection of the prostate on erectile function in patients with benign prostatic hyperplasia. Korean J Urol 2010;51(8):557560. DOI:10.4111/kju.2010.51.8.557. PMID: 20733962.; Gravas S., Bach T., Bachmann A. et al. EAU Guidelines on Management of Non- Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). Eur Assoc Urol, 2016. Available at: http://uroweb.org/wpcontent/uploads/EAU-Guidelines-Management-of-non-neurogenic-male-LUTS-2016. pdf.; Soderdahl D. W., Knight R. W., Hansberry K. L. Erectile dysfunction following transurethral resection of the prostate. J Urol 1996;156:1354–6. PMID: 8808870.; Taher A. Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors. World J Urol 2004;22:457–60. DOI:10.1007/s00345‑004‑0449‑1. PMID: 15503048.; Miner M., Rosenberg M. T., Perelman M. A. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function. Clin Ther 2006;28:13–25. DOI:10.1016/j.clinthera. 2006.01.004. PMID: 16490576.; Elshal A. M., El-Assmy A., Mekkawy R. et al. Prospective controlled assessment of men’s sexual function changes following Holmium laser enucleation of the prostate for treatment of benign prostate hyperplasia. Int Urol Nephrol 2017;49(10):1741–9. DOI:10.1007/s11255‑017‑1649‑0. PMID: 28780626.; Ефремов Е. А., Дорофеев С. Д. Эректильная дисфункция у пациентов, перенесших трансуретральные эндоскопические оперативные вмешательства на предстательной железе по поводу ее доброкачественной гиперплазии. Русский медицинский журнал. Хирургия. Урология 2004;12(8(208)):527–33. [Efremov E.A., Dorofeev S.D. Erectile dysfunction in patients after transurethral endoscopic operative interventions on the prostate due to its benign hyperplasia. Russkiy meditsinskiy zhurnal. Khirurgiya. Urologiya = Russian Medical Journal. Surgery. Urology 2004;12(8(208)):527–33. (In Russ.)].; Muntener M., Aellig S., Kuettel R. et al. Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol 2007;52: 510–6. DOI:10.1016/j.eururo.2007.01.088. PMID: 17306446.; Rassweiler J., Teber D., Kuntz R., Hofmann R. Complications of transurethral resection of the prostate (TURP) – incidence, management and prevention. Eur Urol 2006;50:969–80. DOI:10.1016/j.eururo.2005.12.042. PMID: 16469429.; Аляев Ю. Г., Винаров А. З., Чалый М. Е. и др. Причины эректильной дисфункции после трансуретральной резекции гиперплазированной предстательной железы и ее профилактика. Урология 2005;3:28–32. [Alyaev Yu. G., Vinarov A. Z., Chaliy M. E. et al. Causes of erectile dysfunction after transurethral resection of hyperplastic prostate and its prevention. Urologiya = Urology 2005;3:28–32. (In Russ.)].; Bishop P. Bipolar transurethral resection of the prostate – a new approach. AORN J 2003;77(5):979–83. PMID: 12769328.; D’elia G., Mastrangeli B. A randomized prospective trial of bipolar versus standard monopolar transurethral resection of the prostate. Abstracts Book of the XIXth Congress of EAU, Vienna 2004, A. 113.; Eaton A. C., Francis R. N. The provision of transurethral prostatectomy on a daycase basis using bipolar plasma kinetic technology. BJU Int 2002;89(6):534. PMID: 11942959.; Xie J. B., Tan Y. A., Wang F. L. Extraperitoneal laparoscopic adenomectomy (Madigan) versus bipolar transurethral resection of the prostate for benign prostatic hyperplasia greater than 80 ml: complications and functional outcomes after 3-year follow-up. J Endourol 2014;28:353–9. DOI:10.1089/end.2013.0374. PMID: 24229434.; Pu X., Wang X., Wang H., Hu L. Erectile dysfunction after PlasmaKinetic vaporization of the prostate: incidence and risk factors. J Endourol 2006;20(9):693–7. DOI:10.1089/end.2006.20.693. PMID: 16999629.; Аlloussi S. H., Lang C., Eichel R., Alloussi S. Ejaculation-preserving transurethral resection of prostate and bladder neck: short-and long-term results of a new innovative resection technique. J Endourol 2014;28:84–9. DOI:10.1089/end.2013.0093. PMID: 23952037.; Mamoulakis C., Trompetter M., de la Rosette J. Bipolar transurethral resection of the prostate: The “golden standard” reclaims its leading position. Curr Opin rol 2009;19:26–32. DOI:10.1097/MOU.0b013e32831e44da. PMID: 19057207.; Kabalin J. N. Laser prostatectomy performed with a right angle firing neodymium: YAG laser fiber at 40 watts power setting. J Urol 1993;150:95–9. PMID: 7685429.; Norris J. P., Norris D. M., Lee R. D., Rubenstein M. A. Visual laser ablation of the prostate: clinical experience in 108 patients. J Urol 1993;150:1612–4. PMID: 7692096.; Keoghane S. R., Lawrence K. C., Gray A. M. et al. A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3-year follow-up. BJU Int 2000;85(1):74–8. PMID: 10619950.; Maheshwari P. N., Joshi N., Maheshwari R. P. Best laser for prostatectomy in the year 2013. Indian J Urol 2013;29(3):236–43. DOI:10.4103/0970-1591.117286. PMID: 24082446.; Kuntz R. M. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006;49:961–9. DOI:10.1016/j.eururo.2006.03.028. PMID: 16632179.; Misraï V., Rouprêt M., Guillotreau J. et al. Greenlight photoselective vaporisation for benign prostatic hyperplasia: a systematic review. Prog Urol 2013;23(2):77–87. DOI:10.1016/j.purol.2012.10.013. PMID: 23352299.; Bruyere F., Puichaud A., Pereira H. et al. Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 2010;58:207–11. DOI:10.1016/j.eururo.2010.04.027. PMID: 20466480.; Elshal A. M., Elkoushy M. A., Elmansy H. M. et al. Holmium: YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate. J Urol 2014;191:148–54. DOI:10.1016/j.juro.2013.06.113. PMID: 23845460.; Guo Z., Jin X. The volume of prostate can impact the male sexual function following photoselective vaporization of the prostate: results of a prospective analysis of 128 patients with 2-year follow-up. Int Urol Nephrol 2013;45(4):961–6. DOI:10.1007/s11255‑013‑0489‑9. PMID: 23779228.; Kuo R. L., Kim S. C., Lingeman J. E. et al. Holmium laser enucleation of prostate (HoLEP): the Methodist Hospital experience with greater than 75 gram enucleations. J Urol 2003;170:149–52. DOI:10.1097/01.ju.0000070686.56806.a1. PMID: 12796668.; Глыбочко П. В., Аляев Ю. Г., Рапопорт Л. М. и др. Гольмиевая лазерная энуклеация гиперплазии предстательной железы: технические аспекты. Андрология и генитальная хирургия 2015;16(4):62–6. DOI:10.17650/2070‑9781‑2015‑16‑4‑62‑66. [Glybochko P. V., Alyaev Yu. G., Rapoport L. M. et al. Holmium laser enucleation of the prostate hyperplasia: technical aspects. Andrologiya i genitalnaya khirurgiya = Andrology and Genital Surgery 2015;16(4):62–6. DOI:10.17650/2070‑9781‑2015‑16‑4‑62‑66. (In Russ.)].; Placer J., Salvador C., Planas J. et al. Effects of holmium laser enucleation of the prostate on sexual function. J EndoUrol 2015;29:332–9. DOI:10.1089/end.2014.0502. PMID: 25133981.; Glybochko P., Alyaev Yu., Rapoport L. et al. Effect of Holmium Lazer Enucleation of the prostate (HoLEP) on the Sexual Function. J Urol 2017;197:499. DOI: http://dx.doi.org/10.1016/j.juro.2017.02.1071.; Elshal A. M., Elmansy H. M., Elkoushy M. A. Male sexual function outcome after three laser prostate surgical techniques: A single center perspective. Urology 2012;80:1098–104. DOI:10.1016/j.urology.2012.08.001. PMID: 23107401.; Capogrosso P., Ventimiglia E., Ferrari M. et al. Long-term sexual outcomes after holmium laser enucleation of the prostate: which patients could benefit the most? Int J Impot Res 2016;28(5):189–93. DOI:10.1038/ijir.2016.29. PMID: 27465782.; Jeong M. S., Ha S. B., Lee C. J. et al. Serial changes in sexual function following Holmium laser enucleation of the prostate: a short-term follow-up study. Korean J Urol 2012;53(2):104–8. DOI:10.4111/kju.2012.53.2.104. PMID: 22379589.; Briganti A., Naspro R., Gallina A. et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2- center, randomized trial. J Urol 2006;175:1817–21. DOI:10.1016/S0022-5347(05)00983-3. PMID: 16600770.; Meng F., Gao B., Fu Q. et al. Change of sexual function in patients before and after Ho:YAG laser enucleation of the prostate. J Androl 2007;28:259–61. DOI:10.2164/jandrol.106.000372. PMID: 17021335.; Еникеев Д. В., Глыбочко П. В., Аляев Ю. Г. и др. Лазерная энуклеация гиперплазии простаты (HOLEP и THULEP): сравнительный анализ эффективности при лечении рецидивов гиперплазии простаты. Урология 2017;4:152–6. DOI:10.18565/urol.2017.4.50-4. [Enikeev D. V., Glybochko P. V., Alyaev Yu. G. et al. Laser enucleation of the prostate (HOLEP and THULEP): a comparative effectiveness analysis in treating recurrent prostatic hyperplasia. Urologiya = Urology 2017;4:152–6. DOI:10.18565/urol.2017.4.50-4. (In Russ.)].; Saredi G., Pacchetti A., Pirola G. M. et al. Impact of thulium laser enucleation of the prostate on erectile, ejaculatory and urinary functions. Urol Int 2016;97(4): 397–401. DOI:10.1159/000446829. PMID: 27463971.; Carmignani L., Bozzini G., Macchi A. et al. Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia. Asian J Androl 2015;17(5):802–6. DOI:10.4103/1008-682X.139255. PMID: 25652616.; Iacono F., Prezioso D., Lauro G. et al. Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients. BMC Surg 2012;12(Suppl 1):21. DOI:10.1186/1471‑2482‑12-S1-S21. PMID: 23173611.; Chung J. S., Park S. H., Oh C. K. et al. Longitudinal changes in erectile function after thulium: YAG prostatectomy for the treatment of benign prostatic obstruction: a 1-year follow-up study. Lasers Med Sci 2017;32(7):1517–23. DOI:10.1007/s10103‑017‑2273-z. PMID: 28685201.; Tiburtius C., Knipper S., Gross A. J., Netsch C. Impact of thulium VapoEnucleation of the prostate on erectile function: a prospective analysis of 72 patients at 12-month follow-up. Urology 2014;83:175–80. DOI:10.1016/j.urology.2013.08.029. PMID: 24103563.; https://agx.abvpress.ru/jour/article/view/255

الاتاحة: https://agx.abvpress.ru/jour/article/view/255
https://doi.org/10.17650/2070-9781-2017-18-4-12-18

المؤلفون: О. V. Snurnitsina, M. V. Yenikeev, A. N. Nikitin, L. M. Rapoport, D. V. Enikeev, D. G. Tsarichenko, M. V. Lobanov, A. F. Abdusalamov, О. В. Снурницына, М. Э. Еникеев, А. Н. Никитин, Л. М. Рапопорт, Д. В. Еникеев, Д. Г. Цариченко, М. В. Лобанов, А. Ф. Абдусаламов

المصدر: Andrology and Genital Surgery; Том 19, № 4 (2018); 70-77 ; Андрология и генитальная хирургия; Том 19, № 4 (2018); 70-77 ; 2412-8902 ; 2070-9781 ; 10.17650/2070-9781-2018-19-4

مصطلحات موضوعية: сетчатые протезы, hysteroptosis, urogenital prolapse, pelvic floor, transvaginal surgery, mesh prosthesis, гистероптоз, урогенитальный пролапс, тазовое дно, трансвагинальная хирургия

وصف الملف: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/324/295; Moon J.W., Chae H.D. Vaginal approaches using synthetic mesh to treat pelvic organ prolapse. Ann Coloproctol 2016;32(1):7—11. DOI:10.3393/ac.2016.32.1.7. PMID: 26962530.; Rooney K., Kenton K., Mueller E.R. et al. Advanced anterior vaginal wall prolapse is highly correlated with apical prolapse. Am J Obstet Gynecol 2006; 195(6):1837—40. DOI:10.1016/j.ajog.2006.06.065. PMID: 17132485.; Maher C., Baessler K., Glazener C.M. et al. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2007;(3):CD004014. DOI:10.1002/14651858.CD004014.pub3. PMID: 17636742.; Olsen A.L., Smith V.J., Bergstrom J.O. et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89(4):501—6. DOI:10.1016/S0029-7844(97)00058-6. PMID: 9083302.; Committee on Gynecologic Practice. Committee Opinion no. 513: vaginal placement of synthetic mesh for pelvic organ prolapse. Obstet Gynecol 2011;118(6):1459—64. DOI:10.1097/AOG.0b013e31823ed1d9. PMID: 22105294.; Wfeber A.M., Walters M.D., Piedmonte M.R., Ballard L.A. Anterior colporrhaphy: a randomized trial of three surgical techniques. Am J Obstet Gynecol 2001;185(6):1299—304. DOI:10.1067/mob.2001.119081. PMID: 11744900.; Sand P.K., Koduri S., Lobel R.W. et al. Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles. Am J Obstet Gynecol 2001;184(7):1357—62. PMID: 11408853.; Nguyen J.N., Burchette R.J. Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol 2008;111(4):891—8. DOI:10.1097/AOG.0b013e31816a2489. PMID: 18378748.; Lenz F., Doll S., Sohn C., Brocker K.A. Anatomical position of four different transobturator mesh implants for female anterior prolapse repair. Geburtshilfe Frauenheilkd 2012;73(10):1035—41. DOI:10.1055/s-0033-1350700. PMID: 24771893.; U.S. Food and Drug Administration. UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse: FDA Safety Communication. 2011. Available at: http://wayback.archive-it.org/7993/20170722150848/https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm.; Persu C., Chapple C.R., Cauni V. et al. Pelvic Organ Prolapse Quantification System (POP-Q) — a new era in pelvic prolapse staging. J Med Life 2011;4(1):75-81. PMID: 21505577.; Geller E.J., Babb E., Nackley A.G., Zolnoun D. Incidence and risk factors for pelvic pain after mesh implant surgery for the treatment of pelvic floor disorders. J Minim Invasive Gynecol 2016;24(1):67—73. DOI:10.1016/j.jmig.2016.10.001. PMID: 27773810.; https://agx.abvpress.ru/jour/article/view/324

الاتاحة: https://agx.abvpress.ru/jour/article/view/324
https://doi.org/10.17650/2070-9781-2018-19-4-70-77

المؤلفون: D. V. Enikeev, P. V. Glybochko, Yu. G. Alyaev, L. M. Rapoport, M. E. Enikeev, L. G. Spivak, D. G. Tsarichenko, N. I. Sorokin, R. B. Sukhanov, A. M. Dymov, O. Kh. Khamraev, M. Ya. Gaas, M. S. Taratkin, Д. В. Еникеев, П. В. Глыбочко, Ю. Г Аляев, Л. М. Рапопорт, М. Э. Еникеев, Л. Г. Спивак, Д. Г. Цариченко, Н. И. Сорокин, Р. Б. Суханов, А М. Дымов, О. Х. Хамраев, М. Я. Гаас, М. С. Тараткин

المصدر: Andrology and Genital Surgery; Том 18, № 3 (2017); 83-88 ; Андрология и генитальная хирургия; Том 18, № 3 (2017); 83-88 ; 2412-8902 ; 2070-9781 ; 10.17650/2070-9781-2017-18-3

مصطلحات موضوعية: доброкачественная гиперплазия предстательной железы, HoLEP, laser enucleation, monopolar enucleation, removal of prostate adenoma, infravesical obstruction, benign prostatic hyperplasia, лазерная энуклеация, монополярная энуклеация, удаление аденомы предстательной железы, инфравезикальная обструкция

وصف الملف: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/252/236; Kaplan S.A. Re: EAU Guidelines on the Assessment of Non-Neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. J Urol 2016;196(6):1712–4. DOI:10.1016/j.juro.2016.09.017. PMID: 27845123.; Глыбочко П.В., Аляев Ю.Г., Рапопорт Л.М. и др. Гольмиевая лазерная энуклеация гиперплазии предстательной железы: технические аспекты. Андрология и генитальная хирургия 2015;16(4):62–6. [Glybochko P.V., Alyaev Yu.G., Rapoport L.M. et al. Holmium laser enucleation of the prostate hyperplasia: technical aspects. Andrologiya i genital’naya khirurgiya = Andrology and Genital Surgery 2015;16(4):62–6. (In Russ.)]. DOI:10.17650/2070-9781-2015-16-4-62-66.; Hiraoka Y., Lin T., Tsuboi N., Nakagami Y. Transurethral enucleation of benign prostatic hyperplasia. Nihon Ika Daigaku Zasshi 1986;53(2):212–5. PMID: 2423551.; Hiraoka Y., Akimoto M. Transurethral enucleation of benign prostatic hyperplasia. J Urol 1989;142(5):1247–50. PMID: 2478727.; Цариченко Д.Г., Симбердеев Р.Р., Глыбочко П.В. и др. Трансуретральная монополярная энуклеация доброкачественной гиперплазии предстательной железы. Наш опыт. Урология 2016;(4):20–5. [Tsarichenko D.G., Simberdeev R.R., Glybochko P.V. et al. Monopolar transurethral enucleation of benign prostatic hyperplasia. Our experience. Urologiya = Urology 2016;(4):20–5. (In Russ.)].; Gilling P.J., Kennett K., Das A.K. et al. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol 1998;12(5):457–9. DOI:10.1089/ end.1998.12.457. PMID: 9847070.; Tan A.H., Gilling P.J. Holmium laser prostatectomy: current techniques. Urology 2002;60(1):152–6. PMID: 12100945.; Tan A.H., Gilling P.J., Kennett K.M. et al. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003;170(4 Pt 1):1270–4. DOI:10.1097/01.ju.0000086948.55973.00. PMID: 14501739.; Westenberg A., Gilling P., Kennett K. et al. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 2004;172(2):616–9. DOI:10.1097/01.ju.0000132739.57555.d8. PMID: 15247745.; Tooher R., Sutherland P., Costello A. et al. A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol 2004;171(5):1773–81. DOI:10.1097/01.ju.0000113494.03668.6d. PMID: 15076275.; Wilson L.C., Gilling P.J., Williams A. et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 2006;50(3):569–73. DOI:10.1016/j.eururo.2006.04.002. PMID: 16704894.; Gilling P.J., Cass C.B., Cresswell M.D., Fraundorfer M.R. Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 1996;47(1):48–51. PMID: 8560662.; Gilling P.J., Fraundorfer M.R. Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 1998;8(1):11–5. PMID: 17035836.; Fraundorfer M.R., Gilling P.J. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 1998;33(1):69–72. PMID: 9471043.; Cresswell M.D., Cass C.B., Fraundorfer M.R., Gilling P.J. Holmium:YAG laser resection of the prostate: preliminary experience with the first 400 cases. N Z Med J 1997;110(1039):76–8. PMID: 9137301.; Еникеев Д.В., Глыбочко П.В., Аляев Ю.Г. и др. Гольмиевая лазерная энуклеация (HOLEP) при гиперплазии простаты маленьких, больших и гигантских размеров. Практические рекомендации. Опыт более 450 операций. Урология 2016;(4):63–9. [Enikeev D.V., Glybochko P.V., Alyaev Yu.G. et al. Holmium laser enucleation of the prostate (HOLEP) for small, large and giant prostatic hyperplasia. Practical guidelines. Experience of more than 450 surgeries. Urologiya = Urology 2016;(4):63–9. (In Russ.)].; Севрюков Ф.А., Сорокин Д.А., Карпухин И.В. и др. Трансуретральная энуклеация предстательной железы (TUEB) – новый метод биполярной эндоскопической хирургии ДГПЖ. Экспериментальная и клиническая урология 2012;(2):34–6. [Sevryukov F.A., Sorokin D.A., Karpukhin I.V. et al. Transurethral enucleation of the prostate (TUEB) – new option in bipolar endoscopic surgery of BPH. Eksperimental’naya i klinicheskaya urologiya = Experimental and Clinical Urology 2012;(2):34–6. (In Russ.)].; da Silva R.D., Bidikov L., Michaels W. et al. Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature. Can J Urol 2015;22 Suppl 1:30–44. PMID: 26497342.; Kahokehr A.A., Gilling P.J. Which laser works best for benign prostatic hyperplasia? Curr Urol Rep 2013;14(6):614–9. DOI:10.1007/s11934-013-0351-8. PMID: 23780301.; Herrmann T.R., Liatsikos E.N., Nagele U. et al. European Association of Urology guidelines on laser technologies. Actas Urol Esp 2013;37(2):63–78. DOI:10.1016/j.acuro.2012.05.005. PMID: 22989380.; Kyriazis I., Swiniarski P.P., Jutzi S. et al. Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement. World J Urol 2015;33(4):525–30. DOI:10.1007/s00345-015-1529-0. PMID: 25774004.; Netsch C., Bach T., Herrmann T.R. et al. Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach. World J Urol 2013;31(5):1231–8. DOI:10.1007/s00345-012-0894-1. PMID: 22733237.; Bach T., Muschter R., Sroka R. et al. Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 2012;61(2):317–25. DOI:10.1016/j.eururo.2011.10.009. PMID: 22033173.; Herrmann T.R., Liatsikos E.N., Nagele U. et al. EAU guidelines on laser technologies. Eur Urol 2012;61(4):783–95. DOI:10.1016/j.eururo.2012.01.010. PMID: 22285403.; Herrmann T. R. Enucleation is enucleation is enucleation is enucleation. World J Urol 2016;34(10):1353–5. DOI:10.1007/s00345-016-1922-3. PMID: 27585786.; Li M., Qiu J., Hou Q. et al. Endoscopic enucleation versus open prostatectomy for treating large benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. PLoS One 2015;10(3):e0121265. DOI:10.1371/journal.pone.0121265. PMID: 25826453.; Netsch C., Bach T., Herrmann T.R., Gross A.J. Update on the current evidence for Tm:YAG vapoenucleation of the prostate 2014. World J Urol 2015;33(4):517– 24. DOI:10.1007/s00345-014-1417-z. PMID: 25300823.; Netsch C., Engbert A., Bach T., Gross A.J. Long-term outcome following Thulium VapoEnucleation of the prostate. World J Urol 2014;32(6):1551–8. DOI:10.1007/s00345-014-1260-2. PMID: 24531878.; Tiburtius C., Gross A.J., Netsch C. A prospective, randomized comparison of a 1940 nm and a 2013 nm thulium: yttrium-aluminum-garnet laser device for Thulium VapoEnucleation of the prostate (ThuVEP): First results. Indian J Urol 2015;31(1):47–51. DOI:10.4103/0970-1591.148308. PMID: 25624576.; Hong K., Liu Y.Q., Lu J. et al. Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia. Chin Med J (Engl) 2015;128(7):884–9. DOI:10.4103/0366-6999.154282. PMID: 25836607.; https://agx.abvpress.ru/jour/article/view/252

الاتاحة: https://agx.abvpress.ru/jour/article/view/252
https://doi.org/10.17650/2070-9781-2017-18-3-83-88

المؤلفون: P. V. Glybochko, Yu. G. Alyaev, L. M. Rapoport, M. E. Enikeev, D. V. Enikeev, N. I. Sorokin, R. B. Sukhanov, A. M. Dymov, O. Kh. Khamraev, D. S. Davydov, M. S. Taratkin, П. В. Глыбочко, Ю. Г. Аляев, Л. М. Рапопорт, М. Э. Еникеев, Д. В. Еникеев, Н. И. Сорокин, Р. Б. Суханов, А. М. Дымов, О. Х. Хамраев, Д. С. Давыдов, М. С. Тараткин

المساهمون: Российский научный фонд, Программа развития МГУ

المصدر: Andrology and Genital Surgery; Том 16, № 4 (2015); 62-66 ; Андрология и генитальная хирургия; Том 16, № 4 (2015); 62-66 ; 2412-8902 ; 2070-9781 ; 10.17650/2070-9781-2015-16-4

مصطلحات موضوعية: удаление аденомы, holmium laser adenomectomy, benign prostatic hyperplasia, bladder outlet obstruction, removal of the adenoma, гольмиевая лазерная аденомэктомия, доброкачественная гиперплазия предстательной железы, инфравезикальная обструкция

وصف الملف: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/168/159; Gilling P.J., Cass C.B., Cresswell M.D. et al. Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 1996;47(1):48–51.; Gupta N. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostate hyperplasia of > 40 g. Br J Urol Int 2006;97(1):85–9.; Tan A.H., Gilling P.J., Kennett K.M. et al. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003;170(4): 1270–4.; Ahyai S.A., Gilling P.J., Kaplan S.A. et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010;58(3):384–97.; Kuntz R.M., Lehrich K. Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm: a randomized prospective trial of 120 patients. J Urol 2002;168(4):1465–9.; FraundorferM.R., GillingP.J.,KennettK.M., Dunton N.G. Holmium laserresection of the prostate is more cost effective than transurethral resection of the prostate:results of a randomized prospective study. Urology 2001;57(3):454–8.; https://agx.abvpress.ru/jour/article/view/168

الاتاحة: https://agx.abvpress.ru/jour/article/view/168
https://doi.org/10.17650/2070-9781-2015-16-4-62-66